Welby Inc.
Informe acción TSE:4438
Capitalización de mercado: JP¥3.3b
Welby Resultados de beneficios anteriores
Pasado controles de criterios 0/6 No hay datos suficientes sobre los resultados de Welby en los últimos años.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare Services 19.2% Tasa de crecimiento de los ingresos n/a Rentabilidad financiera -40.6% Margen neto -98.5% Próxima actualización de resultados 14 Nov 2024
Actualizaciones de resultados anteriores recientes
Welby Inc. to Report Q3, 2024 Results on Nov 14, 2024 Sep 27
Welby Inc. to Report Q2, 2024 Results on Aug 13, 2024 Jun 28
Welby Inc. to Report Q1, 2024 Results on May 14, 2024 Mar 30
Welby Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024 Dec 05
Second quarter 2023 earnings released: JP¥17.62 loss per share (vs JP¥6.51 loss in 2Q 2022) Aug 14
Full year 2022 earnings released: EPS: JP¥4.21 (vs JP¥16.60 loss in FY 2021) Apr 01
Mostrar todas las actualizaciones
Welby Inc. to Report Q3, 2024 Results on Nov 14, 2024 Sep 27
New major risk - Financial data availability Sep 17
Welby Inc. to Report Q2, 2024 Results on Aug 13, 2024 Jun 28
New minor risk - Shareholder dilution May 01 Welby Inc. announced that it expects to receive ¥499.9993 million in funding from Chubu Electric Power Company, Incorporated Apr 12
Welby Inc. announced that it expects to receive ¥499.9993 million in funding from Chubu Electric Power Company, Incorporated
Here's Why We're Not Too Worried About Welby's (TSE:4438) Cash Burn Situation Apr 10
Welby Inc. to Report Q1, 2024 Results on May 14, 2024 Mar 30
Welby Inc., Annual General Meeting, Mar 29, 2024 Feb 16
Welby Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024 Dec 05
New major risk - Financial data availability Oct 06
Second quarter 2023 earnings released: JP¥17.62 loss per share (vs JP¥6.51 loss in 2Q 2022) Aug 14
Full year 2022 earnings released: EPS: JP¥4.21 (vs JP¥16.60 loss in FY 2021) Apr 01
Full year 2022 earnings released: EPS: JP¥4.21 (vs JP¥16.60 loss in FY 2021) Feb 12
Welby Inc., Annual General Meeting, Mar 28, 2023 Feb 12
Welby Inc. to Report Fiscal Year 2022 Results on Feb 13, 2023 Dec 06
No independent directors Nov 16
Third quarter 2022 earnings released: JP¥14.17 loss per share (vs JP¥2.04 profit in 3Q 2021) Nov 13
Second quarter 2022 earnings released: JP¥6.51 loss per share (vs JP¥13.79 loss in 2Q 2021) Aug 12
No independent directors Apr 27 Welby Inc. to Report Q3, 2022 Results on Nov 11, 2022
Full year 2021 earnings released: JP¥16.60 loss per share (vs JP¥45.17 loss in FY 2020) Apr 02
Welby Inc., Annual General Meeting, Mar 25, 2022 Feb 16
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 14
Third quarter 2021 earnings released: EPS JP¥2.04 (vs JP¥11.25 loss in 3Q 2020) Nov 11
Second quarter 2021 earnings released: JP¥13.79 loss per share (vs JP¥8.84 loss in 2Q 2020) Aug 13
First quarter 2021 earnings released: JP¥8.30 loss per share (vs JP¥8.85 loss in 1Q 2020) May 16
Full year 2020 earnings released: JP¥45.17 loss per share (vs JP¥1.43 loss in FY 2019) Apr 01
Welby Inc., Annual General Meeting, Mar 25, 2021 Feb 17
New 90-day low: JP¥1,144 Jan 22
New 90-day low: JP¥1,395 Dec 12
Welby Inc. to Report Q3, 2020 Results on Nov 10, 2020 Sep 04
Desglose de ingresos y gastos
Cómo gana y gasta dinero Welby. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos TSE:4438 Ingresos, gastos y beneficios (JPY Millions) Fecha Ingresos Beneficios Gastos G+A Gastos de I+D 30 Jun 24 546 -538 837 0 31 Dec 23 575 -505 813 0
Ingresos de calidad: 4438 actualmente no es rentable.
Margen de beneficios creciente: 4438 actualmente no es rentable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: No se ha podido determinar si la tasa de crecimiento año a año de los beneficios de 4438 ha sido positiva en los últimos 5 años, ya que cotiza en bolsa desde hace menos de 3 años.
Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de 4438 en el último año con su promedio de 5 años, ya que actualmente no es rentable.
Beneficios vs. Industria: 4438 no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (11.1%).
Rentabilidad financiera
Alta ROE: 4438 tiene una rentabilidad financiera negativa (-40.63%), ya que actualmente no es rentable.
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":false,"variant":{"name":"disabled","enabled":false},"flagsReady":false,"flagsError":null}
